Richard Alonso

Blockade of CRF1 or V1b receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression

Richard Alonso, Guy Griebel, G Pavone et al. · Molecular Psychiatry · 2003 · 309 citations

Psychoneuroimmunology, Developmental Biology, Molecular Neuroscience +15

Biochemical and pharmacological characterisatioN OF SR141716A, the first potent and selective brain cannabinoid receptor antagonist

Murielle Rinaldi‐Carmona, Francis Barth, Michel Héaulme et al. · Life Sciences · 1995 · 300 citations

Cannabis Use, Molecular Pharmacology, Functional Selectivity +14

Neurochemical, Electrophysiological and Pharmacological Profiles of the Selective Inhibitor of the Glycine Transporter-1 SSR504734, a Potential New Type of Antipsychotic

Ronan Depoortère, Gihad Dargazanli, Genevieve Estenne‐Bouhtou et al. · Neuropsychopharmacology · 2005 · 217 citations · Full text

Neurophysiology, Medicine, Glycine Transporter-1 Ssr504734 +12

SSR240612 [(2 R)-2-[((3 R)-3-(1,3-Benzodioxol-5-yl)-3-{[(6-methoxy-2-naphthyl)sulfonyl]amino}propanoyl)amino]-3-(4-{[2 R,6 S)-2,6-dimethylpiperidinyl]methyl}phenyl)-N-isopropyl-N-methylpropanamide Hydrochloride], a New Nonpeptide Antagonist of the Bradykinin B1 Receptor: Biochemical and Pharmacological Characterization

Jean Gougat, Bernard Ferrari, Lionel Sarran et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 122 citations

Application of fluorescence polarization to the antigen-antibody reaction

Walter B. Dandliker, Harriette C. Schapiro, J.W Meduski et al. · Immunochemistry · 1964 · 118 citations

Immunocytochemical Technique, Fluorescence Polarization, Antibody Engineering +3